The relationship between tumour infiltrating lymphocytes, Epstein–Barr virus and Helicobacter pylori infection in gastric cancer

Descripción del Articulo

Objective: Epstein–Barr virus (EBV) and Helicobacter pylori (HP) infections have been extensively recognised as gastric cancer (GC) triggers, and recent publications suggest they could behave as predictive markers for immune-modulating therapies. Tumour-infiltrating lymphocytes (TILs) have also been...

Descripción completa

Detalles Bibliográficos
Autores: Castañeda, C, Castillo, M, Bernabe, L, Suarez, N, Fassan, M, Sanchez, J, Tello, K, Alatrista, R, Chavez-Pasiuri, I, Ruiz-figueroa, E, Bazan, Y, Barreda, F, Valdivia, D, Meng, W, Chakravarti, A, Taxa Rojas, L, Montenegro, P
Formato: artículo
Fecha de Publicación:2022
Institución:Instituto Nacional de Enfermedades Neoplásicas
Repositorio:INEN-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.inen.sld.pe:20.500.14703/279
Enlace del recurso:https://hdl.handle.net/20.500.14703/279
Nivel de acceso:acceso abierto
Materia:Epstein–Barr virus
Helicobacter pylori
In situ hybridisation
Lymphocytes
https://purl.org/pe-repo/ocde/ford#3.02.21
id INEN_5c9778b006fbb7defdffc0a9319c83bf
oai_identifier_str oai:repositorio.inen.sld.pe:20.500.14703/279
network_acronym_str INEN
network_name_str INEN-Institucional
repository_id_str .
spelling PublicationCastañeda, CCastillo, MBernabe, LSuarez, NFassan, MSanchez, JTello, KAlatrista, RChavez-Pasiuri, IRuiz-figueroa, EBazan, YBarreda, FValdivia, DMeng, WChakravarti, ASanchez, JTaxa Rojas, LMontenegro, P2025-01-02T14:42:08Z2025-01-02T14:42:08Z202210.3332/ECANCER.2022.1362https://hdl.handle.net/20.500.14703/279ecancermedicalscienceObjective: Epstein–Barr virus (EBV) and Helicobacter pylori (HP) infections have been extensively recognised as gastric cancer (GC) triggers, and recent publications suggest they could behave as predictive markers for immune-modulating therapies. Tumour-infiltrating lymphocytes (TILs) have also been identified as a predictive biomarker for immunotherapy in different malignancies. This study aimed to investigate the association between EBV and HP infection with TIL levels in GC. Methods: TIL evaluation in haematoxylin-eosin was performed by a pathologist and density of CD3, CD8 and CD163 positive (immunohistochemistry staining) immune cells was calculated with the use of digital pathology software. EBV infection was detected by in situ hybridisation (ISH) and by quantitative polymerase chain reaction (qPCR). Methylation status of EBV-related genes was detected by PCR and a methylome analysis was performed by the Illumina Infinium MethylationEPIC BeadChip. HP status was detected by qPCR. Results: We included 98 resected GC Peruvian cases in our evaluation. Median TIL percentage was 30. The proportion of EBV+ detected by ISH was 24.1%, of EBV+ detected by qPCR was 41.8%, while 70% showed methylation of EBV-related genes, and 58.21% of cases were HP+. Younger age (p = 0.024), early stages (p = 0.001), HP+ (p = 0.036) and low CD8 density (p = 0.046) were associated with longer overall survival (OS). High TIL level was associated with intestinal subtype (p < 0.001), with grade 2 (p < 0.001), with EBV qPCR+ (p = 0.001), and with methylation of EBV-related genes (p = 0.007). Cases with high TIL level and cases that are EBV positive share eight genes with similarly methylated status in the metabolomic analysis. High CD8 density was associated with EBV PCR+ (p = 0.012) and HP− (0.005). Conclusion: Lower CD8 density and HP+ predict longer OS. High TIL level is associated with EBV+ and methylation of EBV-related genes, while lower CD8 density is associated with HP+ GC. Copyright: © the authorslicensee ecancermedicalscience. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Universidad Cientifica del Sur, Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (under projects #198-2015-FONDECYT and #196-2015-FONDECYT), and INNOVATEPERU (under project #317-PNICP-EC-2014).application/pdfengecancer Global FoundationUKinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/Epstein–Barr virusHelicobacter pyloriIn situ hybridisationLymphocyteshttps://purl.org/pe-repo/ocde/ford#3.02.21The relationship between tumour infiltrating lymphocytes, Epstein–Barr virus and Helicobacter pylori infection in gastric cancerinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionreponame:INEN-Institucionalinstname:Instituto Nacional de Enfermedades Neoplásicasinstacron:INEN20.500.14703/279oai:repositorio.inen.sld.pe:20.500.14703/2792026-02-16T20:44:17.071Zhttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessmetadata.onlyhttps://repositorio.inen.sld.peRepositorio del Instituto Nacional de Enfermedades Neoplásicasrepositorio@inen.sld.pe
dc.title.none.fl_str_mv The relationship between tumour infiltrating lymphocytes, Epstein–Barr virus and Helicobacter pylori infection in gastric cancer
title The relationship between tumour infiltrating lymphocytes, Epstein–Barr virus and Helicobacter pylori infection in gastric cancer
spellingShingle The relationship between tumour infiltrating lymphocytes, Epstein–Barr virus and Helicobacter pylori infection in gastric cancer
Castañeda, C
Epstein–Barr virus
Helicobacter pylori
In situ hybridisation
Lymphocytes
https://purl.org/pe-repo/ocde/ford#3.02.21
title_short The relationship between tumour infiltrating lymphocytes, Epstein–Barr virus and Helicobacter pylori infection in gastric cancer
title_full The relationship between tumour infiltrating lymphocytes, Epstein–Barr virus and Helicobacter pylori infection in gastric cancer
title_fullStr The relationship between tumour infiltrating lymphocytes, Epstein–Barr virus and Helicobacter pylori infection in gastric cancer
title_full_unstemmed The relationship between tumour infiltrating lymphocytes, Epstein–Barr virus and Helicobacter pylori infection in gastric cancer
title_sort The relationship between tumour infiltrating lymphocytes, Epstein–Barr virus and Helicobacter pylori infection in gastric cancer
author Castañeda, C
author_facet Castañeda, C
Castillo, M
Bernabe, L
Suarez, N
Fassan, M
Sanchez, J
Tello, K
Alatrista, R
Chavez-Pasiuri, I
Ruiz-figueroa, E
Bazan, Y
Barreda, F
Valdivia, D
Meng, W
Chakravarti, A
Taxa Rojas, L
Montenegro, P
author_role author
author2 Castillo, M
Bernabe, L
Suarez, N
Fassan, M
Sanchez, J
Tello, K
Alatrista, R
Chavez-Pasiuri, I
Ruiz-figueroa, E
Bazan, Y
Barreda, F
Valdivia, D
Meng, W
Chakravarti, A
Taxa Rojas, L
Montenegro, P
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Castañeda, C
Castillo, M
Bernabe, L
Suarez, N
Fassan, M
Sanchez, J
Tello, K
Alatrista, R
Chavez-Pasiuri, I
Ruiz-figueroa, E
Bazan, Y
Barreda, F
Valdivia, D
Meng, W
Chakravarti, A
Sanchez, J
Taxa Rojas, L
Montenegro, P
dc.subject.none.fl_str_mv Epstein–Barr virus
Helicobacter pylori
In situ hybridisation
Lymphocytes
topic Epstein–Barr virus
Helicobacter pylori
In situ hybridisation
Lymphocytes
https://purl.org/pe-repo/ocde/ford#3.02.21
dc.subject.ocde.none.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.02.21
description Objective: Epstein–Barr virus (EBV) and Helicobacter pylori (HP) infections have been extensively recognised as gastric cancer (GC) triggers, and recent publications suggest they could behave as predictive markers for immune-modulating therapies. Tumour-infiltrating lymphocytes (TILs) have also been identified as a predictive biomarker for immunotherapy in different malignancies. This study aimed to investigate the association between EBV and HP infection with TIL levels in GC. Methods: TIL evaluation in haematoxylin-eosin was performed by a pathologist and density of CD3, CD8 and CD163 positive (immunohistochemistry staining) immune cells was calculated with the use of digital pathology software. EBV infection was detected by in situ hybridisation (ISH) and by quantitative polymerase chain reaction (qPCR). Methylation status of EBV-related genes was detected by PCR and a methylome analysis was performed by the Illumina Infinium MethylationEPIC BeadChip. HP status was detected by qPCR. Results: We included 98 resected GC Peruvian cases in our evaluation. Median TIL percentage was 30. The proportion of EBV+ detected by ISH was 24.1%, of EBV+ detected by qPCR was 41.8%, while 70% showed methylation of EBV-related genes, and 58.21% of cases were HP+. Younger age (p = 0.024), early stages (p = 0.001), HP+ (p = 0.036) and low CD8 density (p = 0.046) were associated with longer overall survival (OS). High TIL level was associated with intestinal subtype (p < 0.001), with grade 2 (p < 0.001), with EBV qPCR+ (p = 0.001), and with methylation of EBV-related genes (p = 0.007). Cases with high TIL level and cases that are EBV positive share eight genes with similarly methylated status in the metabolomic analysis. High CD8 density was associated with EBV PCR+ (p = 0.012) and HP− (0.005). Conclusion: Lower CD8 density and HP+ predict longer OS. High TIL level is associated with EBV+ and methylation of EBV-related genes, while lower CD8 density is associated with HP+ GC. Copyright: © the authors
publishDate 2022
dc.date.accessioned.none.fl_str_mv 2025-01-02T14:42:08Z
dc.date.available.none.fl_str_mv 2025-01-02T14:42:08Z
dc.date.issued.fl_str_mv 2022
dc.type.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.doi.none.fl_str_mv 10.3332/ECANCER.2022.1362
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.14703/279
dc.identifier.journal.none.fl_str_mv ecancermedicalscience
identifier_str_mv 10.3332/ECANCER.2022.1362
ecancermedicalscience
url https://hdl.handle.net/20.500.14703/279
dc.language.iso.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv ecancer Global Foundation
dc.publisher.country.none.fl_str_mv UK
publisher.none.fl_str_mv ecancer Global Foundation
dc.source.none.fl_str_mv reponame:INEN-Institucional
instname:Instituto Nacional de Enfermedades Neoplásicas
instacron:INEN
instname_str Instituto Nacional de Enfermedades Neoplásicas
instacron_str INEN
institution INEN
reponame_str INEN-Institucional
collection INEN-Institucional
repository.name.fl_str_mv Repositorio del Instituto Nacional de Enfermedades Neoplásicas
repository.mail.fl_str_mv repositorio@inen.sld.pe
_version_ 1865267638756704256
score 13.390862
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).